- Consolidated quarterly revenue hits a record $37.8 million
- Both Service and Distribution segment revenue grow 25%
- Earnings per diluted share improve 20% to $0.18
ROCHESTER, N.Y., Jan. 30, 2017 -- Transcat, Inc. (NASDAQ:TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today reported financial results for its third quarter, which ended December 24, 2016 (the “third quarter”) of fiscal year 2017, ending March 25, 2017 (“fiscal 2017”).
Lee D. Rudow, President and CEO, commented, “We had a record setting quarter driven by strong revenue and margin performance in both of our business segments.
We had high single-digit organic Service revenue growth as we performed particularly well in our targeted life science sector. We also benefited from solid performance from our recent acquisitions. All in all, our Service segment revenue grew 25% year-over-year. We had a 120 basis point increase in gross margin, and while we may not see that kind of improvement every quarter, we expect margins to expand as we continue to build volume, integrate our acquisitions and further leverage our capital investments in the Service segment.
The sequential improvement of our Distribution segment has also been encouraging as we delivered our second consecutive quarter of revenue growth. Our strategy to diversify our Distribution offerings, including equipment rentals and used equipment sales, is contributing to the growth in this segment. In the third quarter, we saw increases in our quote activity, sales leads, and web traffic, all of which led to growth in both core product and alternative energy sales.”
Third Quarter Fiscal 2017 Review (Results are compared with the third quarter of the fiscal year ended March 26, 2016 (“fiscal 2016”))
| ($ in thousands) | Change | ||||||||||||
| FY17 Q3 | FY16 Q3 | ||||||||||||